Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis

E-ISSN： 2212-4055|9|3|158-172

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.9, Iss.3, 2010-07, pp. : 158-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Juvenile idiopathic arthritis: current and future treatment options

By Martini Giorgia Zulian Francesco

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 387-399

Informa Healthcare

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

By Imbach P.

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 795-801

Adis International

Access to resources Recommend Favorite

Current and emerging drugs for idiopathic pulmonary fibrosis

By Gharaee-Kermani Mehrnaz Hu Biao Thannickal Victor J Phan Sem H Gyetko Margaret R

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 627-646

Informa Healthcare

Access to resources Recommend Favorite

New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis

By Ding Qiang Luckhardt Tracy Hecker Louise Zhou Yong Liu Gang Antony Veena B. deAndrade Joao Thannickal Victor J.

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 981-1001

Adis International

Access to resources Recommend Favorite